MedTrace Logo

Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection

NCT00769392 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2020-03-09

Study results available
· View outcomes & findings →

Summary

This study is designed to compare four currently used types of anesthesia used prior to intravitreal injection in order to evaluate the most effective method of anesthesia in reducing pain and discomfort associated with intravitreal injections.

Conditions

  • Macular Degeneration

Interventions

DRUG

Proparacaine Ophthalmic

Drops of Proparacaine on the eye, administered as described in the package insert

DRUG

Tetracaine Ophthalmic

Drops of Tetracaine on the eye, administered as described in the package insert

DRUG

Lidocaine 4%

A cotton sponge(pledget)soaked with Lidocaine 4% placed over the conjunctiva

DRUG

Lidocaine 2% Injectable Solution

A subconjunctival injection of Lidocaine 2%

Sponsors & Collaborators

  • Lahey Clinic

    lead OTHER

Principal Investigators

  • Gregory R. Blaha, M.D., Ph.D. · Lahey Clinic, Inc.

Study Design

Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-08-12
Completion
2009-08-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00769392 on ClinicalTrials.gov